• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Lupin Gets US FDA Approval for Lamotrigine Tablets

      Posted AtNasdaq.com

      MUMBAI -(Dow Jones)- Indian generic drug maker Lupin Ltd. (500257.BY) said Friday its U.S. unit has received final approval from the U.S Food and Drug Administration to make and sell Lamotrigine tablets.

      The approval is for tablets in strengths of 25 milligrams, 100 mg, 150 mg and 200 mg, the company said in a filing to the Bombay Stock Exchange.

      Lamotrigine is the generic form of GlaxoSmithKline's (GSK) Lamictal tablets and is used for the treatment of Epilepsy and bipolar disorder.

      Lamotrigine tablets have annual U.S. sales of about $452 million, the company said, citing data from IMS Health market research.

      June 16, 2010


      Share this Article!

    Back to top^